jaguar.health (JAGX): Net earnings per share for the last 12 months

Graphic logo of Jaguar Health (JAGX)

Lisa Conte's steady course ensures the stability of Jaguar Health, Inc. leadership. The 12-month rolling specific income metric links this management to the financial result, where -2200.74 shows the current volume of the indicator. Jaguar Health, Inc. generates revenue from the sale of patented anti-diarrheal products, while operational reliability is achieved through South American raw materials and US-based CMO plants.

JAGX Jaguar Health Corp Earnings per share for the last four quarters (07/04/2022 - 11/18/2026)

Analytical breakdowns for Jaguar Health, Inc.

- stock price and consensus target price:
Analysis of all company metrics:jaguar.health (JAGX)
Manufactured products of Jaguar Health Corp

Investors are assessing the potential of Jaguar Health, Inc. (JAGX) through the business's ability to generate real cash flow. This metric is calculated by dividing the total annual net income by the total number of shares, measuring the actual yield of each security. An analysis of net income per share over the last four quarters allows for tracking the sales efficiency of specialized diarrhea therapy drugs. Positive dynamics confirm an increase in the pharmaceutical business's margins. A steady increase in this indicator serves as a signal for long-term investment.